Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006
(1998; 49 pages) [French] [Spanish]
Resumen
Health sector reform is a process aimed at improving equity, quality, and efficiency in the health sector through changes in the organization and financing of health services. In this context, the role of WHO today is to explore and promote ways of organizing health services which respond better to the objectives of equity, quality, and efficiency. Nearly every aspect of national drug policy and pharmaceutical sector development is directly or indirectly affected by health reform initiatives. This paper focuses primarily on certain financial aspects of health reform. Some attention is also given to key organizational reforms. Several related topics are not covered in this paper, but are addressed in other activities of the Action Programme on Essential Drugs. Examples of such topics include public-private roles in the pharmaceutical sector, and the impact of the World Trade Organization and associated trade agreements on access to essential drugs.
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Financing reforms
Abrir esta carpeta y ver su contenido3. Affordability and efficiency
Abrir esta carpeta y ver su contenido4. Organizational reforms
Ver el documentoConclusions
Ver el documentoReferences
Ver el documentoBack Cover
 

Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006

WHO/DAP/98.3
Original: English
Distribution: General

World Health Organization

Health Economics and Drugs
DAP Series No. 6

Germán Velásquez
Yvette Madrid
Jonathan D. Quick

Action Programme on Essential Drugs

© World Health Organization (1998)

This document is not a formal publication of the World Health Organization, and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.

The views expressed in documents by named authors are solely the responsibility of those authors.

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 5 noviembre 2014